ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
8 hedge funds and large institutions have $4.2M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+4
Holders Change %
+100%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
3
Closed
–
Calls
$4.85M
Puts
$5K
Net Calls
+$4.85M
Net Calls Change
+$4.24M
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
$1.14M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$944K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
$400K |
| 4 |
Morgan Stanley
New York
|
$389K |
| 5 |
Goldman Sachs
New York
|
$316K |
Top Sellers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
$177K |
| 2 |
CG
Cutler Group
San Francisco,
California
|
$68K |
| 3 |
Jane Street
New York
|
$769K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $1.14M | +$1.14M | +15,706 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $944K | +$944K | +13,034 | New |
|
|
3
Jane Street
New York
| $769K | -$152K | -2,091 | -16% |
|
|
4
Simplex Trading
Chicago,
Illinois
| $400K | +$400K | +5,531 | New |
|
|
5
Morgan Stanley
New York
| $389K | +$339K | +4,680 | +679% |
|
|
6
Goldman Sachs
New York
| $316K | +$316K | +4,367 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $177K | -$522K | -7,179 | -75% |
|
|
CG
8
Cutler Group
San Francisco,
California
| $68K | -$383K | -5,350 | -85% |
|